Amicus Therapeutics to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference

CRANBURY, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present at the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020 at 8:00 a.m. ET.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

https://ir.amicusrx.com/events-and-presentations

.

About Amicus Therapeutics

Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at

www.amicusrx.com

, and follow on

Twitter

and

LinkedIn

.